FULGENT GENETICS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
FULGENT GENETICS, INC. (FLGT) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$42.80 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-17.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-03-17
- FULGENT GENETICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$39.42M.
- FULGENT GENETICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-12-31 was -$225.00K.
- FULGENT GENETICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$42.80M.
- FULGENT GENETICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$2.03M.
- FULGENT GENETICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$731.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|
| 2016-12-31 | -$39.42M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | -$42.80M 10-K · filed 2017-03-17 | |
| 2016-09-30 | -$3.38M 10-Q · filed 2016-11-14 | ||
| 2015-12-31 | -$225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | -$2.03M 10-K · filed 2017-03-17 | |
| 2015-09-30 | -$1.80M 10-Q · filed 2016-11-14 | ||
| 2014-12-31 | -$731.00K 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |